The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

Market Growth and Evolution

• Recent Market Expansion:
  • The DNA/RNA sample extraction and isolation market grew from $2.33 billion in 2023 to $2.52 billion in 2024, with a CAGR of 8.3%.
• Historical Growth Drivers:
  • Advancements in genomics research
  • Increasing demand for personalized medicine
  • Rise in genetic disorders
  • Growing investments in life sciences research
  • Technological advancements in extraction techniques

Future Outlook and Projections

• Anticipated Market Growth:
  • Expected to reach $3.3 billion by 2028, with a CAGR of 6.9%.
• Future Growth Drivers:
  • Expanding applications of genomics in diagnostics and drug development
  • Rising adoption of precision medicine
  • Increasing awareness and focus on genetic testing
  • Continuous advancements in sample extraction technologies
  • Growing collaborations and partnerships in biotechnology

View More On The DNA or RNA Sample Extraction And Isolation Market Report 2024 – https://www.thebusinessresearchcompany.com/report/dna-or-rna-sample-extraction-and-isolation-global-market-report

Impact of Infectious Diseases on Market Dynamics

• Role of DNA/RNA Extraction:
  • Essential for PCR-based diagnostic tests detecting genetic material of pathogens.
  • Facilitates precise identification and management of infectious agents.
  • Example: Global HIV population increased to 39 million in 2022, with 1.3 million new infections reported; rising cases of tuberculosis in the US.

Key Players in the Market

• Leading Companies:
  • F Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • MilliporeSigma
  • Agilent Technologies
  • Illumina Inc.
  • PerkinElmer Inc.
  • Sigma-Aldrich
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Qiagen N.V.
  • Eppendorf AG
  • Macherey-Nagel Gmbh & Co. KG
  • Tecan Group

Technological Innovations Driving Market Growth

• Adoption of Automated Solutions:
  • Automated sample preparation and analysis streamline processes.
  • Example: Qiagen N.V. launched TissueLyser III and RNeasy PowerMax Soil Pro Kit for efficient RNA isolation from diverse biological samples.

Strategic Acquisitions and Expansions

• Merck & Co. Inc.’s Acquisition Strategy:
  • Acquired Prometheus Biosciences Inc. for $10.8 billion in June 2023.
  • Focus on expanding immunology portfolio and advancing DNA/RNA extraction technologies.

Market Segmentation Insights

• By Product:
  • Consumables
  • Instruments
• By Technology:
  • Consumable-Based Technology
  • Instrument-Based Technology
• By Application:
  • PCR, NGS, Cloning, Microarray, Blotting Techniques, Others
• By End-User:
  • Clinical Diagnostic and Forensic Laboratories
  • Research Academics and Institutions
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CRO)
  • Other End-Users

Regional Market Dynamics

• North America: Largest market in 2023.
• Asia-Pacific: Expected to be the fastest-growing region.

The DNA/RNA sample extraction and isolation market is poised for significant growth driven by technological advancements, expanding applications in diagnostics and drug development, and increased focus on genetic testing. With ongoing innovations and strategic expansions, the market is set to meet rising demands in healthcare and biotechnology sectors globally.

Request A Sample Of The Global DNA or RNA Sample Extraction And Isolation Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=13842&type=smp